Companies / Simmunome
Simmunome
Simmunome is a health and biotech AI company based in Montréal, Quebec. It raised a C$2M pre-seed round in September 2023 led by Theodorus.
AI disease simulation platform for drug target validation and patient biomarkers.
simmunome.com- Founded
- 2016
- Category
- Health/
Bio AI - Status
- Active
- Disclosed raised
- C$2M
Funding history
| Round | Date | Amount | Investors |
|---|---|---|---|
| Pre-seed | Sep 18, 2023 | C$2M | Theodorus (lead); Investissement Québec (Eurêka Fund), BKR Capital, Sandpiper Ventures, ACET Capital. C$2M all-equity pre-seed closed early September 2023, announced Sep 18; led by Theodorus Investment Funds with Fonds d'investissement Eurêka (Investissement Québec), BKR Capital, Sandpiper Ventures and ACET Capital |
Founders
- Armstrong Murira, Co-founder/CEO.
- Nardin Nakhla, Co-founder/CTO.
Sources
Data as of November 10, 2026.